Stay updated on Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-11T04:36:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-04T00:26:40.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:55:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-02-17T15:30:08.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:53:44.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.2%
    Check dated 2025-02-03T08:30:58.000Z thumbnail image

Stay in the know with updates to Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.